Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein

计划入组 103 人 · 首次发布于 2017 年 11 月 17 日

Headache Prevalence and Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody -Associated Disease (MOGAD)

计划入组 25 人 · 首次发布于 2026 年 3 月 18 日

Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

计划入组 102 人 · 首次发布于 2024 年 6 月 11 日

MOG-CAR-Tregs cell therapy (Sangamo Therapeutics)

Myelin oligodendrocyte glycoprotein gene therapy (University of Florida)

ROR antagonists (inflammatory disorder)

THE PARKINSON'S AND MOVEMENT DISORDER INSTITUTE

United States

Vanda Pharmaceuticals

United States

Alzamend Neuro

United States

Neurologists See CAR T Potential in Neuro-Immune Diseases, but Safety and Logistics Will Shape Adoption

Oligodendrocyte NRF2 deficiency drives myelin pathology in age-related cognitive decline

IL-6 Receptor Blockers Show Promise for Preventing Relapses in Rare Autoimmune Neurological Disorder MOGAD